Merrick has entered a definitive agreement to acquire AI Medical Systems for approximately CHF2.3bn ($2.3bn).

The acquisition includes AI Medical’s proprietary artificial intelligence algorithms and machine learning, which will be used to diagnose diseases in patients before they feel the symptoms, improving the survival rate.

The transaction is expected to be closed by the end of the year, subject to certain closing conditions and regulatory approvals.

Based in Switzerland, Merrick is a biotechnology manufacturing company, while AI Medical Systems is a Germany-based AI-based healthcare company.

The acquisition is part of Merrick’s expansion strategy and will provide the company with competitive advantages.

Teleflex has acquired Essential Medical for an undisclosed amount.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The acquisition will expand Teleflex’s presence in structural heart and endovascular aneurysm repair markets by the inclusion of Essential Medical’s Manta Vascular Closure Device, a system used to close large bore arteriotomies after procedures.

“Teleflex aims to leverage its position in the interventional cardiology market to boost the penetration and adoption of the device globally.”

Teleflex aims to leverage its position in the interventional cardiology market to boost the penetration and adoption of the device globally.

Wright Medical Group has completed the acquisition of Cartiva for a cash consideration of $435m.

The two companies entered a definitive agreement for the acquisition in August.

The acquisition will add Cartiva’s Synthetic Cartilage Implant (SCI), which received pre-market approval in the US in July 2016, to Wright’s portfolio. The device has also received approvals in the EU, Canada, Brazil, Chile, and Australia.

The purchase is expected to expand Wright’s growth opportunities in the global extremities market.